News in the Life Sciences Industry

NEW YORK, Dec. 6, 2019 /PRNewswire/ -- The Conference Forum announced that patients with experience in clinical trials will take center stage at the Read more ››

STAINES-UPON-THAMES, United Kingdom, Dec. 5, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK) today announced (1) the final results of the previously announced offers by its wholly owned subsidiaries, Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC (the "Issuers") to Eligible... Read more ››

Chronolife's innovative T-shirt-based platform captures biometrics to track chronic conditions such as heart disease

Precision's Unique Combination Of Clinical Services And Translational Sciences Is Recognised For Biotech Industry Innovation

OnBase platform will deliver content management solutions to meet hospital's clinical, financial and operational needs

Seasoned tech CEO Spiegelberg appointed to drive Doctorlink's expansion

OSLO, Norway, Dec. 4, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that new data from preclinical studies investigating the effect of Betalutin® ((177)Lu-lilotomab satetraxetan) on non-Hodgkin's lymphoma (NHL) cell lines will be presented in a poster at the 61(st) American... Read more ››

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK), one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck, a leading science and technology... Read more ››

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Merck, a leading science and technology company, signed a strategic collaboration agreement today with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK).... Read more ››

CHICAGO, Dec. 3, 2019 /PRNewswire/ -- In a significant policy shift, the US FDA has released a guidance for insulin biosimilars on 26 November 2019 [see below, FDA Insulin Guidance] waiving clinical immunogenicity and comparative efficacy testing if the biosimilar insulin candidate matches the... Read more ››

KNARESBOROUGH, England, Dec. 3, 2019 /PRNewswire/ -- TSG Consulting, a leading regulatory and scientific consulting organization, today opens its booth at Biocides Europe 2019 in Vienna, Austria. As part of the two-day conference, TSG's Steven Buchanan, former ECHA Scientific Officer, will speak... Read more ››

LONDON, Dec. 3, 2019 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the completion of the first surgeries utilizing its new JOURNEY II Unicompartmental Knee (UK) System. Built on the heritage of the most clinically successful partial... Read more ››